This public procurement record has 9 releases in its history.

Award

12 Nov 2026 at 10:00

Award

12 Nov 2026 at 09:58

Award

12 Nov 2026 at 09:54

Award

12 Nov 2026 at 09:54

Award

12 Nov 2026 at 09:50

Award

12 Nov 2026 at 09:49

Award

12 Nov 2026 at 09:47

Award

12 Nov 2026 at 09:45

Award

27 Oct 2026 at 12:40

Summary of the contracting process

Manchester University NHS Foundation Trust is buying Multiplex Ligation-dependent Probe Amplification (MLPA) reagents for the North West Genomic Laboratory Hub. These laboratory reagents are used to detect DNA copy-number changes and methylation patterns associated with disease. The requirement covers the MLPA probes and reagents used in the laboratory testing process; the department already has the instruments needed to use them. The goods are for the Trust’s genomic laboratory service in the North West. The supplier, MRC Holland, develops and manufactures the MLPA reagents and probes. The procurement is for chemical laboratory reagents rather than equipment or a wider laboratory service.

The procurement is complete and the contract was awarded to MRC Holland. The Trust used a direct award, relying on the supplier’s ownership of the MLPA technique and associated intellectual property rights. The award value is £669,612 excluding VAT (£803,534 including VAT). The contract period runs from 24 November 2026 to 23 November 2028. The award date is not stated in the published data. The requirement is organised as a single lot. The stated basis for selecting the supplier was its intellectual property rights over the technique; no scored evaluation criteria or additional eligibility conditions are set out. This was a single-supplier procurement under the statutory exception for intellectual property or exclusive rights.

This award shows demand from Manchester University NHS Foundation Trust for specialist MLPA probes and reagents for genomic testing, at a substantial scale and over a two-year contract. The supplier selected was the developer and manufacturer of the MLPA technique, with intellectual property rights that the Trust treated as exclusive. For a future opportunity of this kind, a credible competitor would need to supply reagents compatible with the laboratory’s existing instruments and demonstrate reliable performance for detecting disease-associated DNA copy-number changes and methylation patterns. Because this procurement was justified by the incumbent supplier’s ownership of the technique and exclusive rights, suppliers offering alternative products would need to establish that they meet the laboratory requirement and address the relevant intellectual property position. The evidence points to a specialist diagnostics-reagent market, not a general laboratory consumables requirement.

How relevant is this notice?

Notice Information

Notice Title

Procurement of Multiplex Ligation-Dependent Probe Amplification (MLPA) Reagents

Notice Description

Provision of MLPA reagents for Northwest GLH from MRC Holland. MRC Holland develop and supply probes and reagents for the detection of DNA copy number changes and methylation patterns associated with disease. MRC Holland are the inventors and manufacturers of reagents used in the laboratory process - MLPA. The instruments required for use with the MLPA reagents are already present in the department. PA23 Sch.5 Single supplier - intellectual property or exclusive rights

Procurement Information

Supplier owns and developed the MLPA technique and holds the intellectual property rights

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07912e
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/107417-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33696300 - Chemical reagents

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£669,612 £500K-£1M
Contracts Value
Not specified

Notice Dates

Publication Date
12 Nov 20264 days ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
12 Nov 20265 days ago
Contract Period
24 Nov 2026 - 23 Nov 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Manchester University NHS Foundation Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
TRAFFORD
Postcode
M41 5SL
Postcode Area
Manchester
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD3 Greater Manchester
Small Region (ITL 3)
TLD34 Greater Manchester South West
Delivery Location
Not specified

Local Authority
Trafford
Electoral Ward
Davyhulme
Westminster Constituency
Stretford and Urmston

Supplier Information

Number of Suppliers
1
Supplier Name

MRC Holland B.V.

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...